Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Meta-analysis of the impact of alpha-glucosidase inhibitors on incident diabetes and cardiovascular outcomes

Journal article

Coleman RL. et al, (2019), Cardiovascular Diabetology, 18

Long-term risk of cardiovascular disease in individuals with latent autoimmune diabetes in adults (UKPDS 85).

Journal article

Maddaloni E. et al, (2019), Diabetes Obes Metab, 21, 2115 - 2122

Risk factors for heart failure in the ACE trial population

Conference paper

Scott CAB. et al, (2019), DIABETOLOGIA, 62, S515 - S515

Risk of cardiovascular disease in individuals with latent autoimmune diabetes of adults: results from the UKPDS

Conference paper

Maddaloni E. et al, (2018), DIABETOLOGIA, 61, S574 - S575

Baseline characteristics and temporal differences in Acarbose Cardiovascular Evaluation (ACE) trial participants.

Journal article

Theodorakis MJ. et al, (2018), Am Heart J, 199, 170 - 175

Health selection into neighborhoods among patients enrolled in a clinical trial.

Journal article

Arcaya MC. et al, (2017), Prev Med Rep, 8, 51 - 54

Predicting post one-year durability of glucose-lowering monotherapies in patients with new-onset type 2 diabetes

Conference paper

Agbaje OF. et al, (2017), DIABETOLOGIA, 60, S300 - S300

Risk of anaemia with long-term metformin use in a community setting

Conference paper

Donnelly LA. et al, (2017), DIABETOLOGIA, 60, S139 - S139

Load More